Ann Wieman, DPM
Podiatrist · Warrenton, MONPI 1366557290
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 94 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Organogenesis Inc. accounts for 68.3% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2022 at $547 and has fallen 55.9% since, to $241 in 2025.
Across 94 payments — averaging $18.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$1K
- Kerecis Limited$115
- Koya Medical, Inc.$101
- Bioventus LLC$48
- Zimvie Inc.$45
- ETS Wound Care LLC$45
- plus $194 from 7 others
What the payments were for
- Food & beverage$1,729100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 68 | $1,181 |
| Kerecis Limited | 5 | $115 |
| Koya Medical, Inc. | 1 | $101 |
| Bioventus LLC | 2 | $48 |
| Zimvie Inc. | 2 | $45 |
| ETS Wound Care LLC | 5 | $45 |
| Smith+Nephew | 3 | $43 |
| Integra Lifesciences Corporation | 2 | $38 |
| Medtronic | 1 | $35 |
| Tactile Systems Technology Inc | 2 | $34 |
| Paragon 28, Inc. | 1 | $19 |
| Lifenet Health | 1 | $13 |
| Misonix Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Koya Medical$202
- Dayspring$202
- PuraPly$156
How this compares
$1,729 in reported general payments places this provider in the 55th percentile of 105 podiatrist providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 33 | $732 |
| Ciclopirox | 31 | $692 |
| Mupirocin | 20 | $332 |
| Ketoconazole | 15 | $184 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $135 |
| Doxycycline Hyclate | 15 | $133 |
| Meloxicam | 11 | $48 |
| Cephalexin | 13 | $32 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Warrenton
- Ellen ColganWarrenton$10K
- Ann WilsonWarrenton$2K
- William DukeJefferson City$54K
- Kiera Benge-SheaSaint Louis$28K
- Thomas BoldryLiberty$19K
- Ryan FrankIndependence$15K
- Neil ErmitanoSaint Louis$14K
- John HarnessOverland$14K
- Brittany StaplesCreve Coeur$13K
- Daniel NarowitzSaint Louis$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.